By Art Golab and Michael Sandler  | June 30, 2015 Genentech, the maker of Avastin and other expensive cancer drugs, paid physicians and teaching hospitals more than any other drug or device company in 2014, according to a new round of data published Tuesday on the CMS’ Open Payments website. The data reveal payments made for research, gifts, speaking fees, meals […]